Currently out of the existing stock ratings of Steve Dechert, 6 are a BUY (100%).

Steve Dechert

Work Performance Price Targets & Ratings Chart

Analyst Steve Dechert, currently employed at KEYBANK, carries an average stock price target met ratio of 25% that have a potential upside of 19.59% achieved within 7 days.

Steve Dechert’s has documented 11 price targets and ratings displayed on 3 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ELAN, Elanco Animal Health at 06-Aug-2026.

Wall Street Analyst Steve Dechert

Analyst best performing recommendations are on LFMD (LIFEMD).
The best stock recommendation documented was for LFMD (LIFEMD) at 4/16/2025. The price target of $7 was fulfilled within 13 days with a profit of $1.97 (39.17%) receiving and performance score of 30.13.

Average potential price target upside

ELAN Elanco Animal Health LFMD LifeMD LFST Lifestance Health Group

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 21-Nov-2025

$30

$6.33 (26.74%)

$29

Buy Since 09-Dec-2024

$33

$9.33 (39.42%)

$27

Hold Since 29-Jan-2025

$26

$2.33 (9.84%)

$24

Buy Since 15-Oct-2018

$32

$7.43 (30.24%)

$15

Buy Since 19-Feb-2026

$30

$5.43 (22.10%)

$28

Show more analysts

Please expand the browser size to see the chart

Which stock is Steve Dechert is most bullish on?

Potential upside of $6.33 has been obtained for ELAN (ELANCO ANIMAL HEALTH)

What Year was the first public recommendation made by Steve Dechert?

On 2025

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?